CA3006365A1 - Derives aminophosphiniques pour la prevention et le traitement des douleurs oculaires - Google Patents
Derives aminophosphiniques pour la prevention et le traitement des douleurs oculaires Download PDFInfo
- Publication number
- CA3006365A1 CA3006365A1 CA3006365A CA3006365A CA3006365A1 CA 3006365 A1 CA3006365 A1 CA 3006365A1 CA 3006365 A CA3006365 A CA 3006365A CA 3006365 A CA3006365 A CA 3006365A CA 3006365 A1 CA3006365 A1 CA 3006365A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- group
- ethyl
- propionylamino
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts or implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Biochemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1561598 | 2015-11-30 | ||
| FR1561598A FR3044227B1 (fr) | 2015-11-30 | 2015-11-30 | Derives aminophosphiniques pour la prevention et le traitement des douleurs oculaires |
| PCT/EP2016/079285 WO2017093322A1 (fr) | 2015-11-30 | 2016-11-30 | Dérivés aminophosphiniques pour la prévention et le traitement des douleurs oculaires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3006365A1 true CA3006365A1 (fr) | 2017-06-08 |
Family
ID=55346018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3006365A Pending CA3006365A1 (fr) | 2015-11-30 | 2016-11-30 | Derives aminophosphiniques pour la prevention et le traitement des douleurs oculaires |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20180344753A1 (https=) |
| EP (1) | EP3383403B1 (https=) |
| JP (1) | JP6889176B2 (https=) |
| KR (1) | KR102657652B1 (https=) |
| CN (2) | CN108289901B (https=) |
| BR (1) | BR112018010007A2 (https=) |
| CA (1) | CA3006365A1 (https=) |
| DK (1) | DK3383403T3 (https=) |
| ES (1) | ES2773148T3 (https=) |
| FR (1) | FR3044227B1 (https=) |
| IL (1) | IL259562B (https=) |
| MX (1) | MX382921B (https=) |
| TW (1) | TWI729039B (https=) |
| WO (1) | WO2017093322A1 (https=) |
| ZA (1) | ZA201804037B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9993427B2 (en) * | 2013-03-14 | 2018-06-12 | Biorest Ltd. | Liposome formulation and manufacture |
| FR3063635B1 (fr) * | 2017-03-09 | 2019-06-07 | Pharmaleads | Derives aminophosphiniques pour la prevention et le traitement de l'inflammation oculaire |
| TWI771386B (zh) * | 2017-03-09 | 2022-07-21 | 法商領先藥物公司 | 用於預防及治療眼發炎的氨基膦衍生物 |
| FR3104581B1 (fr) * | 2019-12-11 | 2021-11-26 | Pharmaleads | Procédé de préparation industrielle du sel disodique de ((2S)-3-([1,1'-biphenyl]-4-yl)-2-((hydroxy((1R)-1-(((1-(isobutyryloxy)ethoxy)carbonyl)amino)ethyl)phosphoryl) methyl)propanoyl)-L-alanine |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0987291A (ja) * | 1995-09-26 | 1997-03-31 | Wakamoto Pharmaceut Co Ltd | 新規なアラニン誘導体 |
| FR2755135B1 (fr) | 1996-10-25 | 2002-12-27 | Inst Nat Sante Rech Med | Nouveaux derives d'(alpha-aminophosphino)peptides, leur procede de preparation et les compositions qui les contiennent |
| ES2174337T3 (es) * | 1996-12-16 | 2002-11-01 | Alcon Lab Inc | Uso topico de los agonistas opioides kappa para el tratamiento del dolor ocular. |
| FR2777780B1 (fr) * | 1998-04-22 | 2001-05-04 | Inst Nat Sante Rech Med | Derives d'(alpha-aminophosphino) peptides, leur procede de preparation et les compositions qui les contiennent |
| FR2934267B1 (fr) | 2008-07-23 | 2010-08-13 | Pharmaleads | Derives aminophosphiniques utiles dans le traitement de la douleur |
| FR2934627B1 (fr) | 2008-07-29 | 2010-08-13 | Paul Marie Bernard | Dispositif de positionnement et de calage d'un garde corps escamotable sur plateforme support de banches |
| JP2016511246A (ja) * | 2013-02-13 | 2016-04-14 | ノバルティス アーゲー | 局所眼用鎮痛薬 |
-
2015
- 2015-11-30 FR FR1561598A patent/FR3044227B1/fr not_active Expired - Fee Related
-
2016
- 2016-11-30 WO PCT/EP2016/079285 patent/WO2017093322A1/fr not_active Ceased
- 2016-11-30 JP JP2018546763A patent/JP6889176B2/ja active Active
- 2016-11-30 EP EP16809676.6A patent/EP3383403B1/fr active Active
- 2016-11-30 CN CN201680070092.8A patent/CN108289901B/zh active Active
- 2016-11-30 CA CA3006365A patent/CA3006365A1/fr active Pending
- 2016-11-30 BR BR112018010007-2A patent/BR112018010007A2/pt not_active Application Discontinuation
- 2016-11-30 KR KR1020187018504A patent/KR102657652B1/ko active Active
- 2016-11-30 TW TW105139517A patent/TWI729039B/zh active
- 2016-11-30 MX MX2018006580A patent/MX382921B/es unknown
- 2016-11-30 US US15/779,220 patent/US20180344753A1/en not_active Abandoned
- 2016-11-30 DK DK16809676.6T patent/DK3383403T3/da active
- 2016-11-30 CN CN202010893476.8A patent/CN112121008A/zh active Pending
- 2016-11-30 ES ES16809676T patent/ES2773148T3/es active Active
-
2018
- 2018-05-23 IL IL259562A patent/IL259562B/en active IP Right Grant
- 2018-06-15 ZA ZA2018/04037A patent/ZA201804037B/en unknown
-
2019
- 2019-02-11 US US16/272,573 patent/US10688113B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10688113B2 (en) | 2020-06-23 |
| KR102657652B1 (ko) | 2024-04-15 |
| HK1259181A1 (zh) | 2019-11-29 |
| FR3044227B1 (fr) | 2017-11-24 |
| US20180344753A1 (en) | 2018-12-06 |
| JP6889176B2 (ja) | 2021-06-18 |
| TW201726146A (zh) | 2017-08-01 |
| ZA201804037B (en) | 2020-07-29 |
| ES2773148T3 (es) | 2020-07-09 |
| BR112018010007A2 (pt) | 2018-11-21 |
| CN108289901B (zh) | 2021-05-04 |
| MX382921B (es) | 2025-03-13 |
| EP3383403A1 (fr) | 2018-10-10 |
| US20190167701A1 (en) | 2019-06-06 |
| EP3383403B1 (fr) | 2019-12-25 |
| MX2018006580A (es) | 2018-08-01 |
| IL259562B (en) | 2020-08-31 |
| DK3383403T3 (da) | 2020-03-16 |
| WO2017093322A1 (fr) | 2017-06-08 |
| CN108289901A (zh) | 2018-07-17 |
| KR20180095555A (ko) | 2018-08-27 |
| TWI729039B (zh) | 2021-06-01 |
| CN112121008A (zh) | 2020-12-25 |
| FR3044227A1 (fr) | 2017-06-02 |
| JP2018536714A (ja) | 2018-12-13 |
| IL259562A (en) | 2018-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5891913A (en) | Ophthalmic and aural compositions containing diclofenac potassium | |
| AU2003202219B2 (en) | Methods for treating hearing loss | |
| US20070254841A1 (en) | Formulations and methods for treating dry eye | |
| EP3383403B1 (fr) | Dérivés aminophosphiniques pour la prévention et le traitement des douleurs oculaires | |
| JPS6225645B2 (https=) | ||
| EP0403360B1 (fr) | Utilisation de phényléthanolamines pour la préparation de médicaments pour les affections oculaires | |
| IT9020968A1 (it) | Composto farmaceutico a base di un antocianidina per il trattamento di malattie oftalmiche | |
| EP0630240B1 (en) | Method for reducing intraocular pressure in the mammalian eye by administration of gamma aminobutyric acid (gaba) agonists | |
| HU227940B1 (hu) | Flunarizin alkalmazása zöldhályog helyi kezelésére alkalmas gyógyszerkészítmény elõállítására | |
| JP2023067982A (ja) | 眼の炎症を予防及び治療するためのアミノホスフィン誘導体 | |
| FR3063635B1 (fr) | Derives aminophosphiniques pour la prevention et le traitement de l'inflammation oculaire | |
| HK40042434A (en) | Aminophosphinic derivatives for preventing and treating eye pain | |
| HK1259181B (en) | Aminophosphinic derivatives for preventing and treating eye pain | |
| FR2773076A1 (fr) | Utilisation de la flavine-adenine-dinucleotide pour la preparation de compositions ophtalmiques utiles pour le traitement de l'oeil sec | |
| WO2021015647A1 (ru) | Глазные капли для лечения возрастной катаракты ядерного вида |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20211101 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 8TH ANNIV.) - STANDARD Year of fee payment: 8 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20241028 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20241028 Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20241028 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20241029 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20250224 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250225 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250707 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250707 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260112 |